SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-21-006148
Filing Date
2021-02-17
Accepted
2021-02-17 16:11:43
Documents
1
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7453
  Complete submission text file 0001127602-21-006148.txt   8769
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 505 PARK AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address
Machiels Alec (Reporting) CIK: 0001496687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 21644849